T-Antigen does not induce cell mediated immunity in patients with breast cancer
Open Access
- 1 June 1983
- Vol. 51 (11) , 2053-2056
- https://doi.org/10.1002/1097-0142(19830601)51:11<2053::aid-cncr2820511116>3.0.co;2-3
Abstract
A total of 80 subjects with benign and malignant breast disease and healthy controls were studied for reactivity to T-antigen, MN-antigens and phytohemagglutinin (PHA) using the lymphocyte blastogenesis assay. No differences were detected between controls and patients with benign or malignant breast disease in reactivity to T- and MN-antigens. Moreover, there was no differential response to T- and MN-antigens among patients with breast cancer. PHA reactivity, although similar between groups as a whole, was diminished in patients with advanced carcinoma. These findings indicate that T-antigen fails to induce cell mediated immunity in patients with breast cancer.This publication has 7 references indexed in Scilit:
- Carcinoma-associated cytostructural antigenic alterations: Detection by lectin bindingCancer, 1981
- Stress and Schizophrenia: Some Definitional IssuesSchizophrenia Bulletin, 1981
- Lymphocyte Transformation in the Diagnosis of Congenital Toxoplasma InfectionNew England Journal of Medicine, 1980
- Expression of T‐Antigen on Polyagglutinable Erythrocytes and Carcinoma Cells: Preparation of T‐Activated Erythrocytes, Anti‐T Lectin, Anti‐T Absorbed Human Serum and Purified Anti‐T AntibodyVox Sanguinis, 1979
- A method for distinguishing benign from malignant breast lesions utilizing antibody present in normal human seraCancer, 1979
- Blood group MN precursors as human breast carcinoma‐associated antigens and “naturally” occurring human cytotoxins against themCancer, 1976
- Lymphocyte transformation and macrophage migration inhibition by electrofocused and gel-filtered fractions of group A streptococcal filtrateCellular Immunology, 1974